A crucial mechanism by which tumors can escape the anti-tumor immune response is enhanced signaling of the programmed cell death protein 1 (PD-1)/cytotoxic T-lymphocyte antigen-4 (CTLA-4) pathway. Here, CTLA4 is linked to neoplasm.